Cancer Biomakers

Cancer biomarkers are biological molecules or substances that are produced by cancer cells or by the body in response to cancer. These biomarkers can be found in a patient's blood, urine, or tissue samples, and can be used to help diagnose cancer, monitor its progression, and evaluate the effectiveness of treatment.

Cancer biomarkers are of various types which includes genetic biomarkers, protein biomarkers, and imaging biomarkers. Genetic biomarkers are DNA mutations or alterations that can be used to identify specific types of cancer or predict a patient's response to treatment. Protein biomarkers are specific proteins that are produced by cancer cells or by the body in response to cancer. Imaging biomarkers are characteristics seen on medical imaging tests that can indicate the presence or progression of cancer.

The use of cancer biomarkers in diagnosis and treatment has the potential to improve patient outcomes by enabling earlier detection and more personalized treatment plans. However, it is important to note that not all cancer biomarkers are equally reliable, and further research is needed to validate their use in clinical practice.

    Related Conference of Cancer Biomakers

    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE

    Cancer Biomakers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in